Myeloid growth factors in acute myeloid leukemia: systematic review of randomized controlled trials Michael HeuserAntonia ZapfArnold Ganser Original Article 14 September 2010 Pages: 273 - 281
Leukemias induced by altered TRK-signaling are sensitive to mTOR inhibitors in preclinical models Mathias RheinAdrian SchwarzerZhixiong Li Original Article 07 September 2010 Pages: 283 - 292
CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility Zhong-hai YuanQian LiuPing Zhu Original Article 28 September 2010 Pages: 293 - 299
Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 G208R mutation Ulrich DührsenChristian P. KratzHermann Heimpel Original Article 05 October 2010 Pages: 301 - 306
Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia Kais HusseinGuntram BüscheOliver Bock Original Article 15 September 2010 Pages: 307 - 313
Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway Pinelopi ArgyriouSotirios G. PapageorgiouDimitra Rontogianni Original Article 14 September 2010 Pages: 315 - 322
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trialof the Gruppo Italiano per lo Studio dei Linfomi (GISL) Andrea FerrarioFrancesco Merlifor the Gruppo Italiano per lo Studio dei Linfomi Original Article 17 September 2010 Pages: 323 - 330
Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China Qi-fa LiuXiao-jun XuFan-Yi Meng Original Article 25 September 2010 Pages: 331 - 341
Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population Juan XuBing-Xin JiCong-Yan Liu Original Article 25 September 2010 Pages: 343 - 348
Identification of rare hemoglobin variant (Hb Fairfax) causing dominant β-thalassemia phenotype in an Iranian family Mohammad Taghi AkbariMohammad HamidMina Izadyar Letter to the Editor 03 June 2010 Pages: 349 - 351
Hemoglobin OIndonesia in India: a rare observation Anita ChopraChris FisherHaraprasad Pati Letter to the Editor 24 June 2010 Pages: 353 - 354
A case report of concomitant paroxysmal nocturnal hemoglobinuria and heterozygous β-thalassemia Xiao-Lin YinTian-Hong ZhouYuan-Yuan He Letter to the Editor 16 June 2010 Pages: 355 - 356
Diverse phenotypic expression of sickle cell hemoglobin C disease in an Indian family Dilip K. PatelSiris PatelMalay B. Mukherjee Letter to the Editor 17 June 2010 Pages: 357 - 358
Treatment of acute promyelocytic leukaemia in the Jehovah’s Witness population Colm KeanePeter MolleeDevinder Gill Letter to the Editor 06 July 2010 Pages: 359 - 360
Ocular masquerade syndrome as a herald of progression of acute myelogenous leukemia Nicola Y. GanLee Lian KingStephen C. Teoh Letter to the Editor 29 July 2010 Pages: 361 - 362
The Leser–Trelat sign is a associated with acute myeloid leukemia Irfan YavasogluGurhan KadikoyluZahit Bolaman Letter to the Editor 12 August 2010 Pages: 363 - 363
The myeloproliferative neoplasm-associated JAK2 46/1 haplotype is not overrepresented in chronic myelogenous leukemia Ambra SpolveriniAmy V. JonesAlessandro M. Vannucchi Letter to the Editor 16 June 2010 Pages: 365 - 366
Imatinib-resistant lymphoid clone of chronic myelogenous leukemia in blast phase arising from B cell-committed progenitor leukemic stem cells Shinichi KobayashiKen SatoFumihiko Kimura Letter to the Editor 17 June 2010 Pages: 367 - 368